In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

REPLACE-2, ACUITY and HORIZONS trials results from a patient-level pooled analysis: the Impact of bleeding types on mortality after PCI

Clinical Trial Update III

Acute Coronary Syndromes (ACS)



Presenter | see Discussant report

Roxana Mehran, FESC (United States of America)

Presentation webcast


Discussant | see Presenter abstract

William Wijns, FESC (Belgium)

Presentation webcast

 

References


5017-5018

SessionTitle:

Impact of bleeding types on mortality after PCI: Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZONS trials

Notes to editor


This congress report accompanies a presentation given at the ESC Congress 2009. Written by the author himself/herself, this report does not necessarily reflect the opinion of the European Society of Cardiology.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.